
Biologic Solutions



Baltimore, MD – April 6, 2026 — Auxergen Inc. is proud to announce the publication of “Tea Polyphenols in the COVID-19 Era: Mechanistic Insights and Translational Challenges” in the journal Current Issues in Molecular Biology (https://www.mdpi.com/1467-3045/48/4/379). Lead author Harrison
Auxergen creates and sells innovative biocontrol solutions that tackle diseases impacting humans, plants, and the environment; our mission is to substantially reduce the chemical strain on our soils and waterways.
Recognized as a Qualified Maryland Biotechnology Company by the Maryland Department of Commerce, we are one of the most widely published companies in ag-bio in America and foster a fertile ground for biotechnological advancements. Maryland has recognized our value year after year as a QMBC, enabling our investors to receive tax incentives for investing in Auxergen and, thereby, propelling Maryland towards a more prosperous, sustainable future.
Mission
To reduce the use of chemical pesticides in agriculture, to reduce toxic runoff and to promote watershed and environmental health. To search for novel applications of discoveries at the nexus of human, animal and plant diseases.
In essence: To create biologic solutions to promote human, animal and environmental health.
Vision:
Pioneering a future where plant bacterial diseases are a relic of the past and human longevity is maximized.
Working with Auxergen is an opportunity to fuel genuine advancements addressing global challenges in agriculture and the environment. Our work fosters the development of sustainable solutions with substantial returns driven by market demands and groundbreaking innovations.
443.887.4110
info@auxergen.com